您的位置: 首页 > 农业专利 > 详情页

Engineered influenza antigenic polypeptides and immunogenic compositions thereof
专利权人:
Sanofi Pasteur Inc.
发明人:
Strugnell, Tod,Oloo, Eliud
申请号:
AU2017272344
公开号:
AU2017272344A1
申请日:
2017.06.02
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention provides, among other things, a novel and improved method for generating "mosaic" influenza antigenic polypeptides including hemagglutinin (HA) and neuraminidase (NA) polypeptides based on unique combination of epitope patterns that maximize exposure to epitopes present across multiple HA or NA sequences and therefore improved influenza strain coverage. In particular, the present invention provides engineered influenza B hemagglutinin (HA) polypeptides that are comprised of novel combinations of protective epitopes and antigenic regions from multiple influenza B viral strains. Such engineered HA polypeptides have improved properties over HA polypeptides developed through conventional approaches that rely on consensus alignments of viral sequences.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充